Long Term Extension Trial of setmelanotide (RM-493) for patients who have completed a trial of Setmelanotide for the treatment of obesity associated with genetic defects upstream of the MC4 receptor in the leptin-melanocortin pathway

Administered By

Awarded By

Contributors

Start/End

  • July 28, 2020 - July 31, 2025